clinical trial · NCT06930664
A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)
Merck Sharp & Dohme LLC·phase1·completed·n = 146
HealthySotaterceptSotatercept Autoinjector
brief summary
The goal of the study is to learn what happens to different forms of sotatercept medications in a healthy person's body over time. Researchers want to know if there is a difference in the healthy person's body when different forms of sotatercept medications are given.
started
May 16, 2025
primary completion
Nov 11, 2025
completion
Nov 25, 2025
last updated
Dec 15, 2025
official title
A Phase 1 Clinical Study in Healthy Females of Nonchildbearing Potential to Compare the Pharmacokinetics of Sotatercept (MK-7962) Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol